Evidence map›Paper›PMID 27520967›Full record

ArticleRNA (New York, N.Y.)2016

Arginine methylation enhances the RNA chaperone activity of the West Nile virus host factor AUF1 p45.

Susann Friedrich, Tobias Schmidt, Angelika Schierhorn, Hauke Lilie, Grit Szczepankiewicz, Sandra Bergs, Uwe G Liebert, Ralph P Golbik, Sven-Erik Behrens

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Protein arginine methylation in viral infection and antiviral immunity.International journal of biological sciences · 2023
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Cellular consequences of arginine methylation.Cellular and molecular life sciences : CMLS · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Cellular Targets for the Treatment of Flavivirus Infections.Frontiers in cellular and infection microbiology · 2018
    Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Susann FriedrichInstitute of Biochemistry and Biotechnology (NFI), Martin Luther University Halle-Wittenberg, 60120 Halle, Germany.
Tobias SchmidtInstitute of Biochemistry and Biotechnology (NFI), Martin Luther University Halle-Wittenberg, 60120 Halle, Germany.
Angelika SchierhornInstitute of Biochemistry and Biotechnology (NFI), Martin Luther University Halle-Wittenberg, 60120 Halle, Germany.
Hauke LilieInstitute of Biochemistry and Biotechnology (NFI), Martin Luther University Halle-Wittenberg, 60120 Halle, Germany.
Grit SzczepankiewiczInstitute of Virology, Leipzig University, 04130 Leipzig, Germany.
Sandra BergsInstitute of Virology, Leipzig University, 04130 Leipzig, Germany.
Uwe G LiebertInstitute of Virology, Leipzig University, 04130 Leipzig, Germany.
Ralph P GolbikInstitute of Biochemistry and Biotechnology (NFI), Martin Luther University Halle-Wittenberg, 60120 Halle, Germany.
Sven-Erik BehrensInstitute of Biochemistry and Biotechnology (NFI), Martin Luther University Halle-Wittenberg, 60120 Halle, Germany.
Martin Luther University Halle-Wittenberg · DELeipzig University of Applied Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A prerequisite for the intracellular replication process of the Flavivirus West Nile virus (WNV) is the cyclization of the viral RNA genome, which enables the viral replicase to initiate RNA synthesis. Our earlier studies indicated that the p45 isoform of the cellular AU-rich element binding protein 1 (AUF1) has an RNA chaperone activity, which supports RNA cyclization and viral RNA synthesis by destabilizing a stem structure at the WNV RNA's 3'-end. Here we show that in mammalian cells, AUF1 p45 is consistently modified by arginine methylation of its C terminus. By a combination of different experimental approaches, we can demonstrate that the methyltransferase PRMT1 is necessary and sufficient for AUF1 p45 methylation and that PRMT1 is required for efficient WNV replication. Interestingly, in comparison to the nonmethylated AUF1 p45, the methylated AUF1 p45(aDMA) exhibits a significantly increased affinity to the WNV RNA termini. Further data also revealed that the RNA chaperone activity of AUF1 p45(aDMA) is improved and the methylated protein stimulates viral RNA synthesis considerably more efficiently than the nonmethylated AUF1 p45. In addition to its destabilizing RNA chaperone activity, we identified an RNA annealing activity of AUF1 p45, which is not affected by methylation. Arginine methylation of AUF1 p45 thus represents a specific determinant of its RNA chaperone activity while functioning as a WNV host factor. Our data suggest that the methylation modifies the conformation of AUF1 p45 and in this way affects its RNA binding and restructuring activities.

Indexed as

Protein Processing, Post-Translational3' Untranslated RegionsArginineCell Line, TumorHeterogeneous-Nuclear Ribonucleoprotein DHeterogeneous Nuclear Ribonucleoprotein D0HumansMethylationProtein-Arginine N-MethyltransferasesProtein IsoformsRepressor ProteinsRNA, ViralVirus ReplicationWest Nile virus3' Untranslated RegionsArginineHeterogeneous-Nuclear Ribonucleoprotein DHeterogeneous Nuclear Ribonucleoprotein D0HNRNPD protein, humanPRMT1 protein, humanProtein-Arginine N-MethyltransferasesProtein IsoformsRepressor ProteinsRNA, Viralarginine methylationAUF1Flavivirushost factorRNA replicationWest Nile virus

Identifiers

PMID27520967
PMCPMC5029455
OpenAlexW2515732240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.